-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2021 to Q1 2024.
- Lyell Immunopharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $5.02M, a 0.06% decline year-over-year.
- Lyell Immunopharma, Inc. annual Depreciation, Depletion and Amortization for 2023 was $20.3M, a 12.4% increase from 2022.
- Lyell Immunopharma, Inc. annual Depreciation, Depletion and Amortization for 2022 was $18M, a 32.3% increase from 2021.
- Lyell Immunopharma, Inc. annual Depreciation, Depletion and Amortization for 2021 was $13.6M, a 217% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)